View in EDS HTML Full Text PDF Full Text

Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting.

Saved in:
Bibliographic Details
Title: Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting.
Authors: Othman, Ibraheem1,2 (AUTHOR) ibraheem.othman@saskcancer.ca, Moossavi, Seyedeh Zahra2 (AUTHOR), Bayati, Samaneh2,3 (AUTHOR), Chang, Yi Sin2,4 (AUTHOR), Sanjoy, Shubrandu3,5 (AUTHOR), Grzyb, Karolina4,6 (AUTHOR), Sy, Eric2,5 (AUTHOR), Cropper, Kayla2 (AUTHOR), Kassir, Sandy4 (AUTHOR), Sabry, Waleed2,6 (AUTHOR)
Source: Current Oncology. Jun2025, Vol. 32 Issue 6, p296. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11980052
DOI:10.3390/curroncol32060296